{
  "content": ". There was a trend toward reduced mortality in amiodarone-treated patients with nonischemic cardiomyopathy in CHF-STAT. The possibility that amiodarone might reduce mortality in nonischemic cardiomyopathy remained open.",
  "source": "https://jamanetwork.com/journals/jama/fullarticle/208819",
  "chunk_id": "c76cae81-36af-441a-a31c-663fe08ba7d2",
  "similarity_score": 0.33643919229507446,
  "query": "amiodarone beta-blockers mortality death cardiovascular outcomes hazard ratio odds ratio",
  "rank": 46,
  "title": "Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications",
  "authors": "Patricia Vassallo, Richard G. Trohman",
  "year": "2007",
  "journal": "JAMA",
  "reference": "Vassallo, P., & Trohman, R. G. (2007). Prescribing amiodarone: An evidence-based review of clinical indications. JAMA, 298(11), 1312-1322. https://doi.org/10.1001/jama.298.11.1312",
  "doi": "10.1001/jama.298.11.1312",
  "chunk_index": 99,
  "total_chunks": 177,
  "retrieved_at": "2025-07-24T22:33:23.680916"
}